Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by GY Serrano
Cost-Utility Analysis of Secukinumab Use Versus TNF-Α Inhibitors, in Patients With Ankylosing Spondilytis
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Related publications
Ankylosing Spondylitis Disease Activity Score Is Related to NSAID Use, Especially in Patients Treated With TNF-α Inhibitors
PLoS ONE
Multidisciplinary
Cost-Effectiveness Analysis of Secukinumab in Ankylosing Spondylitis: A Canadian Perspective
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Recommendations for Starting Anti TNF-α in Patients With Ankylosing Spondylitis
Reumatismo
Rheumatology
Cost-Utility Analysis of Lurasidone Versus Aripiprazole in Adults With Schizophrenia
PharmacoEconomics
Health Policy
Public Health
Occupational Health
Pharmacology
Environmental
Pms29 - Secukinumab Versus Adalimumab in the Treatment of Ankylosing Spondylitis: A Cost Per Responder Analysis Among 52 Weeks From a Tunisian Perspective.
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Cost Per Response/Remission in Biologics Available in Italy for the Treatment of TNF-α Inhibitors-Naïve Patients With Ulcerative Colitis
Global and Regional Health Technology Assessment
Health Policy
Application of TNF-alpha Inhibitors in Treatment of Uveitis Associated With Ankylosing Spondylitis
Vestnik Oftalmologii
Medicine
Ophthalmology
Do Patients With Ankylosing Spondylitis Adapt to Their Disease? Evidence From a 'Then-Test' in Patients Treated With TNF Inhibitors
RMD Open
Rheumatology
Allergy
Immunology
Pms42 - Secukinumab Versus Adalimumab for the Treatment of Ankylosing Spondylitis: A 52-Week Cost Per Responder Analysis From the Portuguese Payer Perspective
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
